Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
Tabla de Políticas Médicas
| ID | Título | Revisión | Descripción | Acceso |
|---|---|---|---|---|
| 11.001.027 | Immune Cell Function Assay | Jan 2026 | Careful monitoring of lifelong immunosuppression is required to ensure the long-term viability of solid organ... | Ver |
| 11.001.029 | Prueba fibronectina fetal | May 2016 | ... | Ver |
| 11.001.032 | Evaluation of Biomarkers for Alzheimer Disease | Jun 2026 | Biochemical changes associated with the pathophysiology of alzheimer disease (ad) are being evaluated to aid... | Ver |
| 11.001.033 | Bone Turnover Markers For The Diagnosis And Management Of Osteoporosis And Diseases Associated With High Bone Turnover | Jan 2026 | Bone turnover markers are biochemical markers of either bone formation or bone resorption. commercially... | Ver |
| 11.001.034 | Fecal Analysis In The Diagnosis Of Intestinal Dysbiosis | Jan 2026 | Intestinal dysbiosis may be defined as a state of disordered microbial ecology that is believed to cause... | Ver |
| 11.001.036 | Quantitative Assay For Measurement Of Her2 Total Protein Expression And Her2 | Jan 2021 | Novel assays that quantitatively measure total human epidermal growth factor receptor 2 (her2) protein... | Ver |
| 11.001.037 | Intracellular Micronutrient Analysis | Jan 2026 | Commercial laboratories offer panels of tests evaluating intracellular levels of micronutrients (essential... | Ver |
| 11.001.038 | Multitarget Polymerase Chain Traction Testing For Diagnosis Of Bacterial Vaginosis | Jan 2026 | Bacterial vaginosis (bv) is a common medical condition resulting from an imbalance in the normal vaginal... | Ver |
| 11.001.039 | Nutrient/Nutritional Panel Testing | Jan 2026 | Multimarker nutritional panel testing is proposed for patients with certain chronic conditions (eg, mood... | Ver |
| 11.001.040 | Testing Serum Vitamin D Levels | Jan 2026 | Vitamin d, also known as calciferol, is a fat-soluble vitamin that has a variety of physiologic effects, most... | Ver |
| 11.001.041 | Drug Testing In Pain Management And Substance Use Disorder Treatment | Dec 2025 | Individuals in pain management programs and substance use disorder treatment may misuse prescribed opioids... | Ver |
| 11.001.042 | Fecal Calprotectin Testing | Jan 2026 | Calprotectin is a calcium- and zinc-binding protein that is a potential marker of intestinal inflammation.... | Ver |
| 11.001.044 | Antigen Leukocyte Antibody Test | Nov 2025 | The antigen leukocyte antibody test (alcat) is intended to diagnose intolerance to foods and other... | Ver |
| 11.001.046 | Maternal Serum Testing for Prediction of Adverse Obstetric Outcomes | Jun 2026 | ... | Ver |
| 11.001.047 | Multicancer Early Detection Testing | Jul 2025 | Many cancers appear to have a better prognosis if diagnosed early in their natural history. this has led to... | Ver |
| 11.001.048 | Urinary Test for Renal Allograft Rejection | Aug 2025 | Clinical assessment, routine monitoring, and noninvasive imaging of allograft function after renal transplant... | Ver |
| 11.002.001 | Systems Pathology In Prostate Cancer | Dec 2020 | Systems pathology, an approach that combines cellular and biologic features to standard clinical parameters,... | Ver |
| 11.002.003 | Molecular Testing For The Management Of Pancreatic Cysts, Barrett Esophagus, And Solid Pancreaticobiliary Lesions | Dec 2024 | Tests that integrate microscopic analysis with molecular tissue analysis are generally called topographic... | Ver |
| 11.002.004 | Cervical Cancer Screening Technologies With Pap And Hpv | Sep 2025 | Data suggest that cytologic screening for cervical cancer reduces the incidence of cervical cancer by up to... | Ver |
| 11.003.001 | Laboratory Tests For Heart And Kidney Transplant Rejection | Feb 2026 | Clinical assessment and noninvasive imaging of chronic heart failure can be limited in accurately diagnosing... | Ver |